Common use of PERFORMING AGENCY RESPONSIBILITIES Clause in Contracts

PERFORMING AGENCY RESPONSIBILITIES. Performing Agency will: A. Work with System Agency Birth Defects Epidemiology and Surveillance Branch (“BDESB”) staff to identify and select external clinical reviewers (hereafter referred to as “clinical reviewers”) and coordinate work arrangements with these clinicians for birth defects clinical review activities described herein; Each clinical reviewer must meet the minimum qualifications listed below: 1. The clinical reviewer must be a licensed physician in the United States; 2. The clinical reviewer must be an American Board of Medical Genetics and Genomics (“ABMGG”) (formally known as American Board of Medical Genetics ABMG) Board Certified/Board Eligible Clinical Geneticist who participates in the ABMG Maintenance of Certification program and/or completes twenty (20) hours of Continuing Medical Education (“CME”) in genetics annually; and 3. The clinical reviewer must have demonstrated experience in birth defects, embryology, genetic disease, and/or syndrome diagnosis. B. Ensure clinical reviewers participate in training as needed on the coding, database system, and procedures used by BDESB; C. Coordinate and ensure clinical review of selected cases abstracted for the BDESB and identification of corresponding birth defect diagnoses and coding as requested by the BDESB Manager, Registry Operations Manager, Senior Scientist, or other BDESB staff in accordance with the terms of this Contract and all attachments hereto (the “Professional Services”). Case review will include, but is not limited to: 1. Reviewing electronic copies of birth defect cases meeting BDESB criteria for clinical review; 2. Reviewing diagnosis codes of a random subset of birth defect cases for quality assurance purposes; and 3. Reviewing and providing clinical input for cluster investigations, BDESB studies and special projects; D. Ensure clinical reviewers comment electronically, as necessary, on case abstractions, including but not limited to: 1. Documenting needed changes within each case abstraction; 2. Eliminating a case from the database because it does not meet Birth Defects Registry's case definition; and 3. Notifying the System Agency regional field personnel of needed changes, to request more information, or to request abstraction, as needed; ▇. ▇▇▇▇▇▇▇ clinical reviewers’ work as clinical expert as requested by the BDESB Manager, Registry Operations Manager, Senior Scientist, or other BDESB staff, including supervision of the following clinical reviewers’ activities: 1. Participation in Birth Defects Registry cluster investigations, periodic BDESB staff meetings, and temporary targeted working groups, testing the BDESB web-based system for collecting and editing data on cases of birth defects, and helping in projects requiring clinical input; 2. Addressing questions from BDESB staff of a clinical nature such as developing/revising the birth defects coding list, case definition, or other clinical issues; 3. Communicating BDESB issues with physicians who have experience relevant to the diagnosis and treatment of birth defects; and 4. Conducting oral presentations to lay and professional audiences regarding the Birth Defects Registry; F. Ensure clinical reviewers maintain a network of professional specialists and sub-specialists for advice about birth defect delineation and coding. Instruct BDESB staff regarding birth defects diagnosis and coding; G. Ensure clinical reviewers provide training as requested to BDESB staff in birth defect diagnosis and coding, medical record review, and other topics as requested. Training will include: pre-review questions by email or phone, instructions during the process of abstraction correction, email contact, formal training sessions in person or electronically, and writing of training and/or informational materials; H. Ensure clinical reviewers assist with training a new clinical reviewer for BDESB, as needed; I. Ensure clinical reviewers review and refine case review procedures to reduce inter- reviewer variation with System Agency and others, if applicable, upon request by System Agency. Clinical reviewers to document all changes or additions to reviewed procedures; J. Ensure clinical reviewers attend BDESB and selected other meetings and conferences as directed and approved by System Agency; K. Ensure clinical reviewers submit a six-month progress report on activities accomplished, which shall be due at the two BDESB operations and planning meetings each Contract year; L. Ensure all clinical reviewers have access to a secure computer that meets the requirements set forth in the UT System Data Use Agreement, which is attached hereto and incorporated herein as Attachment G and use a Windows operating system and secure internet connection for access to the BDESB web-based system for collecting and editing data on cases of birth defects. Note that the current BDESB system was designed for use with a Personal Computer (“PC”) running the Windows operating system and the browser recommended by the program. The use of other systems is not advised, may cause unexpected results, and cannot be supported by System Agency staff; M. Ensure all clinical reviewers and Performing Agency staff comply with all privacy and security standards set forth in the UT System Data Use Agreement attached hereto and incorporated herein as Attachment G; ▇. ▇▇▇▇▇▇▇ with, and ensure clinical reviewers consult with, other BDESB clinical reviewers and staff by phone, fax, and/or electronic methods; O. Ensure the clinical reviewers keep current all professional licenses and certifications applicable to these services for the term of this Contract; P. Ensure that all clinical reviewers and Performing Agency staff that have access to the birth defects data complete the Department of Information Resources (DIR) certified cybersecurity training on an annual basis; Q. Ensure all clinical reviewers and Performing Agency staff adhere to Texas Health and Safety Code Chapter 87 (▇▇▇▇▇://▇▇▇▇▇▇▇▇.▇▇▇▇▇▇▇.▇▇▇▇▇.▇▇▇/Docs/HS/htm/HS.87.htm), and program rules in 25 Texas Administrative Code Chapter 37, Subchapter P (▇▇▇▇▇://▇▇▇▇▇▇.▇▇▇.▇▇▇▇▇.▇▇.▇▇/public/readtac$ext.ViewTAC?tac view=5&ti=25&pt=1&ch R. Ensure all clinical reviewers sign and adhere to the UT System Data Use Agreement set forth in the UT System Data Use Agreement attached hereto and incorporated herein as Attachment G. In addition, Performing Agency shall ensure that its staff adhere to the UT System Data Use Agreement. Performing Agency to ensure clinical reviewers sign ATTACHMENT 1. SUBCONTRACTOR AGREEMENT FORM and submit the signed Attachment 1 to DSHS; S. Ensure the clinical reviewers commit to spending at least 1,200 combined total hours annually within the Contract term performing clinical review activities for BDESB;

PERFORMING AGENCY RESPONSIBILITIES. Performing Agency will: A. Work with System Agency Birth Defects Epidemiology and Surveillance Branch (“BDESB”) staff to identify and select external clinical reviewers (hereafter referred to as “clinical reviewers”) and coordinate work arrangements with these clinicians for birth defects clinical review activities described herein; Each clinical reviewer must meet the minimum qualifications listed below: 1. The clinical reviewer must be a licensed physician in the United States; 2. The clinical reviewer must be an American Board of Medical Genetics and Genomics (“ABMGG”) (formally known as American Board of Medical Genetics [ABMG) ] Board Certified/Board Eligible Clinical Geneticist who participates in the ABMG Maintenance of Certification program and/or completes twenty (20) hours of Continuing Medical Education (“CME”) in genetics annually; andEducation 3. The clinical reviewer must have demonstrated experience in birth defects, embryology, genetic disease, and/or syndrome diagnosis. B. Ensure clinical reviewers participate in training as needed on the coding, database system, and procedures used by BDESB; C. Coordinate and ensure clinical review of selected cases abstracted for the BDESB and identification of corresponding birth defect diagnoses and coding as requested by the BDESB Manager, Registry Operations Manager, Senior Scientist, or other BDESB staff in accordance with the terms of this Contract and all attachments hereto (the “Professional Services”). Case review will include, but is not limited to:in 1. Reviewing electronic copies of birth defect cases meeting BDESB criteria for clinical review; 2. Reviewing diagnosis codes of a random subset of birth defect cases for quality assurance purposes; and 3. Reviewing and providing clinical input for cluster investigations, BDESB studies and special projects; D. Ensure clinical reviewers comment electronically, as necessary, on case abstractions, including but not limited to: 1. Documenting needed changes within each case abstraction; 2. Eliminating a case from the database because it does not meet Birth Defects Registry's case definition; and 3. Notifying the System Agency regional field personnel of needed changes, to request more information, or to request abstraction, as needed; ▇. ▇▇▇▇▇▇▇ clinical reviewers’ work as clinical E. expert as requested by the BDESB Manager, Registry Operations Manager, Senior Scientist, or other BDESB staff, including supervision of the following clinical reviewers’ activities: 1. Participation in Birth Defects Registry cluster investigations, periodic BDESB staff meetings, and temporary targeted working groups, testing the BDESB web-based system for collecting and editing data on cases of birth defects, and helping in projects requiring clinical input; 2. Addressing questions from BDESB staff of a clinical nature such as developing/revising the birth defects coding list, case definition, or other clinical issues; 3. Communicating BDESB issues with physicians who have experience relevant to the diagnosis and treatment of birth defects; and 4. Conducting oral presentations to lay and professional audiences regarding the Birth Defects Registry; F. Ensure clinical reviewers maintain a network of professional specialists and sub-specialists for advice about birth defect delineation and coding. Instruct BDESB staff regarding birth defects diagnosis and coding; G. Ensure clinical reviewers provide training as requested to BDESB staff in birth defect diagnosis and coding, medical record review, and other topics as requested. Training will include: pre-review questions by email or phone, instructions during the process of abstraction correction, email contact, formal training sessions in person or electronically, and writing of training and/or informational materials; H. Ensure clinical reviewers assist with training a new clinical reviewer for BDESB, as needed; I. Ensure clinical reviewers review and refine case review procedures to reduce inter- reviewer variation with System Agency and others, if applicable, upon request by System Agency. Clinical reviewers to document all changes or additions to reviewed procedures; J. Ensure clinical reviewers attend BDESB and selected other meetings and conferences as directed and approved by System Agency; K. Ensure clinical reviewers submit a six-month progress report on activities accomplished, which shall be due at the two BDESB operations and planning meetings each Contract year; L. Ensure all clinical reviewers have access to a secure computer that meets the requirements set forth in the UT System Data Use Agreement, which is attached hereto and incorporated herein as Attachment G and use a Windows operating system and secure internet connection for access to the BDESB web-based system for collecting and editing data on cases of birth defects. Note that the current BDESB system was designed for use with a Personal Computer (“PC”) running the Windows operating system and the browser recommended by the program. The use of other systems is not advised, may cause unexpected results, and cannot be supported by System Agency staff; M. Ensure all clinical reviewers and Performing Agency staff comply with all privacy and security standards set forth in the UT System Data Use Agreement attached hereto and incorporated herein as Attachment G; ▇. ▇▇▇▇▇▇▇ with, and ensure clinical reviewers consult with, other BDESB clinical reviewers and staff by phone, fax, and/or electronic methods; O. Ensure the clinical reviewers keep current all professional licenses and certifications applicable to these services for the term of this Contract; P. Ensure that all clinical reviewers and Performing Agency staff that have access to the birth defects data complete the Department of Information Resources (DIR) certified cybersecurity training on an annual basis; Q. Ensure all clinical reviewers and Performing Agency staff adhere to Texas Health and Safety Code Chapter 87 (▇▇▇▇▇://▇▇▇▇▇▇▇▇.▇▇▇▇▇▇▇.▇▇▇▇▇.▇▇▇/Docs/HS/htm/HS.87.htm), and program rules in 25 Texas Administrative Code Chapter 37, Subchapter P (▇▇▇▇▇://▇▇▇▇▇▇.▇▇▇.▇▇▇▇▇.▇▇.▇▇/public/readtac$ext.ViewTAC?tac view=5&ti=25&pt=1&ch R. Ensure all clinical reviewers sign and adhere to the UT System Data Use Agreement set forth in the UT System Data Use Agreement attached hereto and incorporated herein as Attachment G. In addition, Performing Agency shall ensure that its staff adhere to the UT System Data Use Agreement. Performing Agency to ensure clinical reviewers sign ATTACHMENT 1. SUBCONTRACTOR AGREEMENT FORM and submit the signed Attachment 1 to DSHS; S. Ensure the clinical reviewers commit to spending at least 1,200 combined total hours annually within the Contract term performing clinical review activities for BDESB;